Home > Qtrly Results > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Quarterly Results Analysis [Dec2025]

AD     Remove this Ad

GLENMARK PHARMACEUTICALS Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹3,901 Cr ₹6,047 Cr ₹3,264 Cr ₹3,256 Cr ₹3,388 Cr ₹3,434 Cr ₹3,244 Cr ₹3,063 Cr
Expenses ₹3,031 Cr ₹3,687 Cr ₹2,684 Cr ₹2,695 Cr ₹2,787 Cr ₹2,832 Cr ₹2,656 Cr ₹2,559 Cr
Operating Income ₹870 Cr ₹2,360 Cr ₹581 Cr ₹561 Cr ₹600 Cr ₹602 Cr ₹588 Cr ₹504 Cr
Other Income ₹44 Cr ₹201 Cr ₹26 Cr ₹12 Cr ₹31 Cr ₹39 Cr ₹31 Cr ₹773 Cr
Interest ₹41 Cr ₹66 Cr ₹58 Cr ₹67 Cr ₹52 Cr ₹48 Cr ₹40 Cr ₹149 Cr
Depreciation ₹154 Cr ₹141 Cr ₹130 Cr ₹125 Cr ₹123 Cr ₹120 Cr ₹118 Cr ₹151 Cr
Profit Before Tax ₹534 Cr ₹967 Cr ₹96 Cr ₹8 Cr ₹456 Cr ₹473 Cr ₹462 Cr ₹531 Cr
Profit After Tax ₹403 Cr ₹610 Cr ₹47 Cr ₹4 Cr ₹348 Cr ₹354 Cr ₹340 Cr ₹-1,239 Cr
EPS ₹14.29 ₹21.63 ₹1.66 ₹0.16 ₹12.33 ₹12.55 ₹12.06 ₹-43.17
Industry Peers & Returns1W1M1Y
GLENMARK PHARMACEUTICALS -1.6% -5.3% 31.8%
SUN PHARMACEUTICAL INDUSTRIES 7.1% -1.5% -6.2%
DIVIS LABORATORIES 2.8% -2.8% 6%
CIPLA 0.2% -12.5% -7.9%
TORRENT PHARMACEUTICALS 3.1% 4.2% 18.8%
DR REDDYS LABORATORIES 2.2% -1.6% 0%
MANKIND PHARMA 2.6% -2.1% -16.6%
ZYDUS LIFESCIENCES 1.4% -1.5% -5.7%
LUPIN 2.6% 3.8% 2.9%

GLENMARK PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-35.49 %

Y-o-Y

15.15 %

Quarters Revenues % Change
Dec2025 ₹3,901 Cr
-35.49
Sep2025 ₹6,047 Cr
85.23
Jun2025 ₹3,264 Cr
0.25
Mar2025 ₹3,256 Cr
-3.88
Dec2024 ₹3,388 Cr
-1.35
Sep2024 ₹3,434 Cr
5.84
Jun2024 ₹3,244 Cr
5.92
Mar2024 ₹3,063 Cr -

GLENMARK PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-63.14 %

Y-o-Y

44.90 %

Quarters Operating Profit % Change
Dec2025 ₹870 Cr
-63.14
Sep2025 ₹2,360 Cr
306.45
Jun2025 ₹581 Cr
3.47
Mar2025 ₹561 Cr
-6.53
Dec2024 ₹600 Cr
-0.28
Sep2024 ₹602 Cr
2.33
Jun2024 ₹588 Cr
16.63
Mar2024 ₹504 Cr -
Operating Margins
Q-o-Q

-42.85 %

Y-o-Y

25.85 %

Quarters Operating Margin% % Change
Dec2025 22.3%
-42.85
Sep2025 39.02%
119.46
Jun2025 17.78%
3.19
Mar2025 17.23%
-2.77
Dec2024 17.72%
1.08
Sep2024 17.53%
-3.31
Jun2024 18.13%
10.08
Mar2024 16.47% -

GLENMARK PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-33.94 %

Y-o-Y

15.86 %

Quarters Profit After Tax % Change
Dec2025 ₹403 Cr
-33.94
Sep2025 ₹610 Cr
1,199.54
Jun2025 ₹47 Cr
971.46
Mar2025 ₹4 Cr
-98.74
Dec2024 ₹348 Cr
-1.82
Sep2024 ₹354 Cr
4.19
Jun2024 ₹340 Cr
Positive
Mar2024 ₹-1,239 Cr -
PAT Margins
Q-o-Q

2.38 %

Y-o-Y

0.68 %

Quarters PAT Margin(%) % Change
Dec2025 10.34 %
2.38
Sep2025 10.1 %
601.39
Jun2025 1.44 %
1,007.69
Mar2025 0.13 %
-98.73
Dec2024 10.27 %
-0.48
Sep2024 10.32 %
-1.62
Jun2024 10.49 %
Positive
Mar2024 -40.44 % -

GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-33.93 %

Y-o-Y

15.90 %

Quarters EPS % Change
Dec2025 ₹14.29
-33.93
Sep2025 ₹21.63
1,203.01
Jun2025 ₹1.66
937.50
Mar2025 ₹0.16
-98.70
Dec2024 ₹12.33
-1.75
Sep2024 ₹12.55
4.06
Jun2024 ₹12.06
Positive
Mar2024 ₹-43.17 -

You may also like the below Video Courses